UnitedHealth CFO DeVeydt reports no UNH shares

UnitedHealth Group’s Chief Financial Officer Wayne S. DeVeydt filed an initial ownership report stating he beneficially owns no UnitedHealth Group common stock.

Rhea-AI Filing Summary

UnitedHealth Group’s Chief Financial Officer Wayne S. DeVeydt filed an initial ownership report stating he beneficially owns no UnitedHealth Group common stock. The Form 3 shows zero shares of common stock held directly and no derivative securities such as options or warrants as of the event date of September 2, 2025. The filing confirms his role as an officer, specifically Chief Financial Officer, and indicates that all reported ownership is direct, with no indirect holdings listed.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DeVeydt Wayne S

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does UnitedHealth (UNH) CFO Wayne S. DeVeydt’s Form 3 filing report?

The Form 3 shows that Wayne S. DeVeydt, Chief Financial Officer of UnitedHealth Group, beneficially owns 0 shares of common stock as of September 2, 2025.

Does UnitedHealth (UNH) CFO Wayne S. DeVeydt hold any derivative securities?

No. The Form 3 table for derivative securities reports no options, warrants, or other derivatives beneficially owned by Wayne S. DeVeydt.

Is Wayne S. DeVeydt’s ownership in UnitedHealth (UNH) direct or indirect?

The filing lists 0 shares of common stock held directly (D) and reports no indirect ownership, with no entities or relationships noted for indirect holdings.

What is Wayne S. DeVeydt’s role at UnitedHealth Group (UNH) according to the Form 3?

The Form 3 identifies Wayne S. DeVeydt as an officer of UnitedHealth Group, with the title Chief Financial Officer.

Who signed the UnitedHealth (UNH) Form 3 for Wayne S. DeVeydt?

The Form 3 is signed by Faraz A. Choudhry as Attorney-in-Fact for Wayne S. DeVeydt, under a Power of Attorney listed as Exhibit 24.

What is the event date reported in the UnitedHealth (UNH) Form 3 for Wayne S. DeVeydt?

The Form 3 lists the Date of Event Requiring Statement as September 2, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/04/2025 - 04:22 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

DeVeydt Wayne S

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/02/2025

3. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney.

	Faraz A. Choudhry, Attorney-in-Fact for Wayne S. DeVeydt	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.